Centessa Pharmaceuticals PLC (CNTA) SEC Filings — 2025
15 SEC filings for Centessa Pharmaceuticals PLC (CNTA) in 2025.
Filings
- Centessa Pharmaceuticals Reports Director/Officer Changes — 8-K · Dec 11, 2025
- Centessa Pharmaceuticals Files 8-K — 8-K · Nov 24, 2025
- Centessa Pharmaceuticals Enters Material Definitive Agreement — 8-K · Nov 13, 2025
- Centessa's Q3 Loss Widens Amid R&D Surge, Cash Drains — 10-Q · Nov 5, 2025
- Centessa's Q2 Loss Widens Amid Soaring R&D Costs — 10-Q · Aug 12, 2025
- Centessa Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Jun 20, 2025
- Centessa Pharmaceuticals Files 8-K — 8-K · Jun 17, 2025
- Centessa Pharmaceuticals Announces Board and Officer Changes — 8-K · May 29, 2025
- Centessa Pharmaceuticals Files DEFA14A Proxy Materials — DEFA14A · May 28, 2025
- Centessa Pharmaceuticals Q1 2025 10-Q Filing — 10-Q · May 14, 2025
- Centessa Pharmaceuticals Files 2025 Proxy Statement — DEF 14A · May 6, 2025
- Centessa Pharmaceuticals Files 8-K on Financials — 8-K · Mar 24, 2025
- Centessa Pharmaceuticals Enters Material Definitive Agreement — 8-K · Feb 21, 2025
- Centessa Pharmaceuticals Files 10-Q/A for Q3 2024 — 10-Q/A · Feb 14, 2025
- Centessa Pharmaceuticals Files 8-K — 8-K · Jan 8, 2025